The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Long-term evaluation of omalizumab therapy in patients with severe allergic asthma”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Akash Kothari, Lisa Hung, Julia E. M. Upton. Considerations for biologics as front-line treatment in allergic diseases, Frontiers in Immunology. 2026; 16: 1746790. https://doi.org/10.3389/fimmu.2025.1746790 |
|
2 |
2026 |
Andrea Portacci, Corrado Pelaia, Diego Bagnasco, Giovanni Paoletti, Santi Nolasco, Amato De Paulis. Lung Function Decline in Asthma: Mechanisms, Risk Factors, and Clinical Implications for Personalized Management, The Journal of Allergy and Clinical Immunology: In Practice. 2026; https://doi.org/10.1016/j.jaip.2026.01.043 |
|
3 |
2026 |
Mario Cazzola, Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, Paola Rogliani. Current and Emerging Biologic Therapies for Severe Asthma, Drugs. 2026; https://doi.org/10.1007/s40265-026-02310-4 |